Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD; Adam S. Cheifetz, MD
Drs Corey Siegel, Gil Melmed, and Adam Cheifetz took to the Open Air Studio at the AIBD annual meeting to discuss an important recent change in FDA labeling for upadacitinib and the positioning of JAK inhibitors in the management of IBD.
Drs Corey Siegel, Gil Melmed, and Adam Cheifetz took to the Open Air Studio at the AIBD annual meeting to discuss an important recent change in FDA labeling for upadacitinib and the positioning of JAK inhibitors in the management of IBD.
Dr Panaccione reviews his presentation at the Advances in IBD annual meeting on extraintestinal manifestations of the nervous system, including peripheral neuropathy, cerebral venous thrombosis, and demylenating disorders.
Dr Panaccione reviews his presentation at the Advances in IBD annual meeting on extraintestinal manifestations of the nervous system, including peripheral neuropathy, cerebral venous thrombosis, and demylenating disorders.
Marla C. Dubinsky, MD; Parambir Dulai, MD; Bruce E. Sands, MD, MS
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
This interview focuses on the most common EGFR inhibitor–associated skin adverse events, when they typically emerge, and practical strategies to reduce severity—including skincare routines, photoprotection, and prophylactic approaches.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Joseph Merola breaks down how dermatologists can accurately interpret autoimmune serologies, with a focus on ANA testing, clinical context, and avoiding unnecessary labs.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Melissa Mauskar discusses common diagnostic pitfalls in vulvar dermatoses, including overlapping conditions and misdiagnosis of lichen sclerosus versus genitourinary syndrome of menopause.
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Dr Emma Guttman explains how chronic hand eczema is now understood as a heterogeneous disease driven by different immune pathways depending on underlying causes.
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Are dermatologists overtesting patients on biologics and new oral therapies? Dr Scott Elman explains how mechanism-based screening can reduce unnecessary testing while maintaining patient safety.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Brad Glick discusses persistent unmet needs in psoriasis care, including undertreatment, low systemic therapy adoption, and challenges in high-impact disease areas.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
Dr Jack O’Brien discusses how dermatologists can reduce diagnostic delays in hidradenitis suppurativa by recognizing early clinical signs such as recurrent abscesses in intertriginous areas and associated acne.
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
This interview examines the limitations of commonly used dermatology outcome measures in patients with skin of color and other underrepresented populations.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Dennis Orgill discusses when dermatologists should involve plastic surgeons after Mohs surgery, particularly for complex defects in high-visibility areas such as the nose, eyes, and mouth.
Dr Daniel Siegel discusses how artificial intelligence and emerging technologies are transforming dermatology practice—from ambient transcription to diagnostic support tools.
Dr Daniel Siegel discusses how artificial intelligence and emerging technologies are transforming dermatology practice—from ambient transcription to diagnostic support tools.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Which therapies work fastest to reduce pain and improve function in rheumatoid arthritis? Research presented at ACR Convergence provides some guidance.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Researchers analyzed data using validated mental health measures and patient-designed questions to assess depression, anxiety, mental wellbeing, and healthcare behaviors.
Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
Dr Bonder reviews presentations from the European Association for Liver Diseases meeting providing updates on treatments for autoimmune liver diseases.
